| Market Capitalization (Millions $) |
23,139 |
| Shares
Outstanding (Millions) |
47 |
| Employees |
1,400 |
| Revenues (TTM) (Millions $) |
3,170 |
| Net Income (TTM) (Millions $) |
1,287 |
| Cash Flow (TTM) (Millions $) |
-620 |
| Capital Exp. (TTM) (Millions $) |
552 |
Business Description
United Therapeutics Corporation is a biotechnology company headquartered in Silver Spring, Maryland. The company is focused on the development, manufacturing, and commercialization of innovative therapies to treat rare disorders and life-threatening diseases. It was founded in 1996 by Martine Rothblatt.
The company has a diverse portfolio of products that includes both therapeutic drugs and wearable technology for remote patient monitoring. It conducts extensive research in pulmonary hypertension (PH), neuroblastoma, and hematologic cancers.
United Therapeutics operates in several business segments: commercial, research and development, and manufacturing. The company has a strong global presence and has offices and facilities in the United States, Europe, and Asia.
One of the key drugs developed by United Therapeutics is called Remodulin, which is used to treat pulmonary arterial hypertension (PAH). PAH is a rare and life-threatening condition that occurs when the blood vessels in the lungs become narrow, leading to high blood pressure and eventual heart failure. Remodulin is administered through a small pump that is connected to a catheter in the patientes chest.
Another drug developed by United Therapeutics is called Tyvaso, which is also used to treat PAH. Tyvaso is an inhaled medication that is delivered through a portable device.
In addition to developing therapies for PAH, United Therapeutics is actively researching treatments for neuroblastoma, a rare cancer that affects children, as well as hematologic cancers such as leukemia and lymphoma.
The company also offers wearable technology for remote patient monitoring. One of the most notable products is the TytoCare device, which allows patients to perform basic medical exams at home and share the data with their healthcare providers.
United Therapeutics has received numerous accolades for its contributions to the biotech industry. In 2017, the company was recognized as one of the worldes most innovative companies by Forbes magazine.
Overall, United Therapeutics Corporation is dedicated to improving the lives of patients with rare and life-threatening diseases through innovative research, manufacturing, and commercialization of high-quality therapies and medical devices.
Company Address: 1000 Spring Street Silver Spring 20910 MD
Company Phone Number: 608-9292 Stock Exchange / Ticker: NASDAQ UTHR
|
1.7% 
42.26 %